A combination of extracellular matrix‐ and interferon‐associated signatures identifies high‐grade breast cancers with poor prognosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A combination of extracellular matrix‐ and interferon‐associated signatures identifies high‐grade breast cancers with poor prognosis
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-02
DOI
10.1002/1878-0261.12912
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The breast tumor microenvironment: role in cancer development, progression and response to therapy
- (2018) Suruchi Mittal et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Developing miRNA signatures: a multivariate prospective
- (2016) Paolo Verderio et al. BRITISH JOURNAL OF CANCER
- Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’—Methodological challenges in combining miRNAs as circulating biomarkers
- (2016) P Verderio et al. BRITISH JOURNAL OF CANCER
- Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
- (2016) Sabina Sangaletti et al. Cell Reports
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients
- (2015) Valeria Musella et al. PLoS One
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
- (2014) A. Prat et al. CLINICAL CANCER RESEARCH
- Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer
- (2014) Maurizio Callari et al. Molecular Oncology
- CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
- (2013) Dandan Lv et al. Cellular & Molecular Immunology
- Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress
- (2013) Tiziana Triulzi et al. PLoS One
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Finding large average submatrices in high dimensional data
- (2009) Andrey A. Shabalin et al. Annals of Applied Statistics
- Anthracyclines and Early Breast Cancer: The End of an Era?
- (2009) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search